Company filings profile · CIK 0001001233

SANGAMO THERAPEUTICS, INC — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for SANGAMO THERAPEUTICS, INC (SGMOQ): 10 filings in the last 90 days vs 16 in the prior 90 (filing-velocity cooling ↓ · 0.63×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 16, 2026. Source-linked, daily-refreshed.

Material 8-K events — SANGAMO THERAPEUTICS, INC

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 16, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Sep 21, 2026Bankruptcy or Receivership; Completion of Acquisition/Disposition; Financial Statements and Exhibits↗
Sep 8, 2026Bankruptcy or Receivership; Completion of Acquisition/Disposition; Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 28, 2026Entry into a Material Agreement; Bankruptcy or Receivership; Financial Statements and Exhibits↗
Aug 13, 2026Other Events; Financial Statements and Exhibits↗
Aug 12, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Jul 20, 2026Bankruptcy or Receivership; Delisting / Listing-Rule Failure↗
Jul 1, 2026Change in Auditor; Other Events; Financial Statements and Exhibits↗
Jun 23, 2026Entry into a Material Agreement; Bankruptcy or Receivership; Material Direct Financial Obligation; Costs of Exit/Disposal Activities↗
May 14, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Apr 29, 2026Delisting / Listing-Rule Failure↗
Mar 30, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Feb 4, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits↗

Watch SANGAMO THERAPEUTICS, INC automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
May 27, 20264↗
May 27, 20264↗
May 27, 20264↗
May 27, 20264↗
May 27, 20264↗
Apr 23, 20264↗
Apr 23, 20264↗
Apr 3, 20264↗
Apr 3, 20264↗
Apr 3, 20264↗
Apr 3, 20264↗
Apr 3, 20264↗
Feb 26, 20264↗
Feb 26, 20264↗
Feb 26, 20264↗
Feb 26, 20264↗
Feb 26, 20264↗
Jan 26, 20264↗
Jan 26, 20264↗
Jan 26, 20264↗

Recent filings

FiledFormDetail
Oct 16, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Oct 7, 202625-NSE ↗
Sep 21, 20268-K Bankruptcy or Receivership; Completion of Acquisition/Disposition; Financial Statements and Exhibits ↗
Sep 8, 20268-K Bankruptcy or Receivership; Completion of Acquisition/Disposition; Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 28, 20268-K Entry into a Material Agreement; Bankruptcy or Receivership; Financial Statements and Exhibits ↗
Aug 17, 2026NT 10-Q NT 10-Q ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 13, 20268-K Other Events; Financial Statements and Exhibits ↗
Aug 12, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jul 20, 20268-K Bankruptcy or Receivership; Delisting / Listing-Rule Failure ↗
Jul 1, 20268-K Change in Auditor; Other Events; Financial Statements and Exhibits ↗
Jun 23, 20268-K/A Financial Statements and Exhibits ↗
Jun 23, 20268-K Entry into a Material Agreement; Bankruptcy or Receivership; Material Direct Financial Obligation; Costs of Exit/Disposal Activities ↗
May 27, 20264 ↗
May 27, 20264 ↗
May 27, 20264 ↗
May 27, 20264 ↗
May 27, 20264 ↗
May 15, 2026SCHEDULE 13G ↗
May 14, 202610-Q 10-Q ↗
May 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Apr 30, 202610-K/A 10-K/A ↗
Apr 29, 20268-K Delisting / Listing-Rule Failure ↗
Apr 23, 20264 ↗
Apr 23, 20264 ↗
Apr 22, 2026144 ↗
Apr 6, 2026144 ↗
Apr 3, 20264 ↗
Apr 3, 20264 ↗
Apr 3, 20264 ↗
Apr 3, 20264 ↗
Apr 3, 20264 ↗
Mar 30, 202610-K 10-K ↗
Mar 30, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Feb 26, 20264 ↗
Feb 26, 20264 ↗
Feb 26, 20264 ↗
Feb 26, 20264 ↗
Feb 26, 20264 ↗
Feb 4, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits ↗